Overview

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Status:
NOT_YET_RECRUITING

Trial end date:
2026-11-01

Target enrollment:

Participant gender:

Summary

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

Phase:

PHASE2

Details

Lead Sponsor:

Vanda Pharmaceuticals

Treatments:

iloperidone